Page last updated: 2024-11-06

prednisolone and Ochronosis

prednisolone has been researched along with Ochronosis in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Ochronosis: The yellowish discoloration of connective tissue due to deposition of HOMOGENTISIC ACID (a brown-black pigment). This is due to defects in the metabolism of PHENYLALANINE and TYROSINE. Ochronosis occurs in ALKAPTONURIA, but has also been associated with exposure to certain chemicals (e.g., PHENOL, trinitrophenol, BENZENE DERIVATIVES).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karimzadeh, H1
Mohtasham, N1
Karimifar, M1
Salesi, M1
Bonakdar, ZS1
Hüttl, S1
Markovic, O1
Sitaj, S1

Other Studies

2 other studies available for prednisolone and Ochronosis

ArticleYear
A case of ochronosis with gout and Monckeberg arteries.
    Rheumatology international, 2009, Volume: 29, Issue:12

    Topics: Aged; Allopurinol; Anti-Inflammatory Agents; Gout; Gout Suppressants; Hand; Humans; Male; Monckeberg

2009
[Hemarthrosis in ochronotic arthropathy].
    Zeitschrift fur Rheumaforschung, 1966, Volume: 25, Issue:5

    Topics: Alkaptonuria; Blood Proteins; Cell Membrane Permeability; Hemarthrosis; Histocytochemistry; Humans;

1966